TABLE 1.
Source | Region | N (control/AD) | Change in Controls (mean ± SD per year) | Change in AD (mean ± SD per year) | Difference per year |
---|---|---|---|---|---|
Kaye et al.79 | Hippocampi | 18/12 (preclinical AD) | −2.09% | −2.33% | −0.14% |
Parahippocampal gyri | −2.16% | −2.92% | −0.76% | ||
Temporal lobes | 0% | −1.27% | −1.27%* | ||
Whole brain volume | 0.27% | 0.08% | 0.19% | ||
Jack et al.84 | Hippocampi | 24/24 | −1.55% ± 1.38% | −3.98% ± 1.92% | −2.43%* |
Temporal horns | 6.15% ± 7.69% | 14.16% ± 8.47% | 8.01%* | ||
Fox et al.89 | Whole brain volume | 18/18 | −0.41% ± 0.47% | −2.37% ± 1.11% | −1.96%* |
Laakso et al.85† | Right hippocampus | 8/27 | −1.6% ± 15.1% | −6.9% ± 18.2% | −5.3% |
Left hippocampus | −3.6% ± 15.1% | −7.2% ± 20.1% | −3.6% | ||
Teipel et al.87 | Corpus callosum (total) | 10/21 | −0.9% ± 5.0% | −7.7% ± 6.7% | −6.8%* |
C1 (rostrum and genu) | 1.6% ± 6.3% | −12.1% ± 15.1% | −13.7%* | ||
C2 (anterior truncus) | 3.9% ± 12.1% | −10.3% ± 18.8% | −14.2%* | ||
C3 (middle truncus) | −1.6% ± 9.5% | −3.0% ± 10.6% | −1.4% | ||
C4 (posterior truncus) | −3.7% ± 12.7% | 4.0% ± 18.1% | 7.7% | ||
C5 (splenium) | 0.7% ± 3.6% | −7.3% ± 9.3% | −8%* | ||
Bradley et al.97 | Brain volume | 32/5 | −0.2% ± 0.23% | −2.14% ± 0.52% | −1.94%* |
Ventricle volume | 4.1% ± 0.9% | 13.0% ± 2.4% | 8.9%* | ||
Ventricle/brain ratio | −4.3% ± 1.1% | −15.6% ± 2.8% | −11.3%* | ||
Wang et al.91 | Cerebrum | 14/14 | −0.4% ± 0.5% | −2.4% ± 1.2% | −2%* |
Lateral ventricles | 1.9% ± 4.2% | 13.8% ± 4.8% | 11.9%* | ||
Temporal lobes | −0.7% ± 0.5% | −3.4% ± 2.0% | −2.7%* | ||
Silbert et al.81 | CNS volume | 24/15 | −1.8 cc ± 9.6 cc | −17.9 cc ± 18.0 cc | −16.1 cc |
Ventricle volume | 3.3 cc ± 3.5 cc | 5.5 cc ± 3.2 cc | 2.2 cc |
There is a statistically significant difference between the rate of change in controls and patients with AD.
Change in 3 years.